Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To register, simply click the Register button at the top right.
The old blood was from patients selected with the Oxford criteria. Persons with findings you mention, would been excluded.
Cort wrote: Another was from a prominent CFS researcher currently studying the role of endogenous retroviruses play in CFS (Huber). Another was from a Canadian virologist who has apparently been a passionate advocate for CFS for many years (Joliceur).
I have heard rumours about these studies but have not seen data.
The 101 patients studied in (1) were "patients fulfilling the 1994 CDC Fukuda criteria for chronic fatigue syndrome and the 2003 Canadian Consensus Criteria for chronic fatigue syndrome/myalgic encephalitis (CFS/ME) and presenting with severe disability" [supporting online material for (1)], but the latter requires physical signs precluded in the former.
That was the Kuppeveld study and Dr. Mikovits reported that 2/7 of the samples were positive for XMRV at the WPI. None of them would have been excluded because a) the Oxford definition does not preclude any abnormal findings - as is so often reported - and b) 20 years ago none of those tests were even available, so they couldn't have tested for them and t herefore couldn't known if they were positive or negative.
Cort, if my memory serves me, I think the reason Mikovits has responded to those studies so publicly was because of McClure's (? I think that's the right name) public comments about contamination of WPI. This was in a newspaper after the first UK study was published. This was a public attack on the credibility of WPI and could possibly stop future researchers from looking into XMRV in CFS.
So Mikovits then needed to respond to set the record straight in the same manner the accusation was made.
Now, the third study also needed some response because of inaccurate information put in the news media based on the second study. Mikovits needed to let it be know this other lab chose not to mention that WPI found some positives in their samples. That was unethical and since that study, again, could influence public policy and funding for XMRV in CFS, the record needed to be set straight, publicly, since the study and media comments afterward were made publicly. Actually, though, the response was made by Anne Whittemore to McClure in a letter, which was put out publicly.
But all of this was in response to Mikovits' initial comments made after the Science journal publication to the effect that this should solve the whole psychological debate in UK. (I think Anne might have said something to the same effect.) This, though, was not a criticism of other retrovirus researchers. It was a public exposure of Wessley.
So it seems the public barbs increased gradually, with multiple parties involved.
This may sound childish, but between retrovirus researchers, McClure started it. LOL
I don't know how I feel about Mikovits' comment against the psychologizers. She was, no doubt, trying to stand up for a group who have been mistreated, in her view. If Wessley responded publicly, I could say the back and forth was not good and Mikovits started.
But as far as between retrovirus researchers, it was the first comment of contamination that was out of line. And it is entirely appropriate for Mikovits to set the record straight for the public since the accusation was made in public.
Tina
The results of both studies were reported at conferences.
Wessely and his gang, say it is Fukuda that excludes physical signs.
http://www.sciencemag.org/cgi/content/full/328/5980/825-b
Attended by you I guess but not available for me as far as I know.
Nijmegen said they exclude everyone who has anything known to cause fatique and/or show symptoms of an infection.
I wonder why you give a list of findings for which no test were available back then.
Rnase-L was indeed published later.
Mikovits reported it but Nijmegen did not. I am not sure the positive samples were from the 1992 cohort.
Cort, which studies did this? I heard by indirect reports from one of the conferences that Huber had tested a WPI positive sample, but apart from this I was not aware that any studies had used WPI reagents, or samples? Can you point us to where this information is posted?
I wonder which physical signs they're referring to.
Nijmegen said they exclude everyone who has anything known to cause fatique and/or show symptoms of an infection.
I wonder why you give a list of findings for which no test were available back then.
Rnase-L was indeed published later.
On the CDC website, under Diagnosis of CFS, there is the following "There are no physical signs that identify CFS". http://www.cdc.gov/cfs/cfsbasicfacts.htm
I think this is sloppy by the CDC, as clearly there are. They do say 'identify', so I guess Wessely misread it.
I guess a sign is something you see. The Canadian criteria lists a few of those.